$16.00B Market Cap.
MRNA Market Cap. (MRY)
MRNA Shares Outstanding (MRY)
MRNA Assets (MRY)
Total Assets
$14.14B
Total Liabilities
$3.24B
Total Investments
$7.59B
MRNA Income (MRY)
Revenue
$3.24B
Net Income
-$3.56B
Operating Expense
$5.72B
MRNA Cash Flow (MRY)
CF Operations
-$3.00B
CF Investing
$1.95B
CF Financing
$56.00M
MRNA Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
MRNA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $14,142,000,000 (-23.25%) | $18,426,000,000 (-28.74%) | $25,858,000,000 (4.82%) | $24,669,000,000 (236.23%) |
Assets Current | $8,099,000,000 (-21.56%) | $10,325,000,000 (-23.13%) | $13,431,000,000 (-16.43%) | $16,071,000,000 (155.18%) |
Assets Non-Current | $6,043,000,000 (-25.40%) | $8,101,000,000 (-34.81%) | $12,427,000,000 (44.53%) | $8,598,000,000 (727.53%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $10,901,000,000 (-21.32%) | $13,854,000,000 (-27.55%) | $19,123,000,000 (35.19%) | $14,145,000,000 (452.32%) |
Property Plant & Equipment Net | $2,955,000,000 (11.17%) | $2,658,000,000 (24.26%) | $2,139,000,000 (54.66%) | $1,383,000,000 (257.36%) |
Cash & Equivalents | $1,927,000,000 (-33.71%) | $2,907,000,000 (-9.30%) | $3,205,000,000 (-53.20%) | $6,848,000,000 (160.98%) |
Accumulated Other Comprehensive Income | -$10,000,000 (91.87%) | -$123,000,000 (66.76%) | -$370,000,000 (-1441.67%) | -$24,000,000 (-900.00%) |
Deferred Revenue | $211,000,000 (-67.59%) | $651,000,000 (-75.99%) | $2,711,000,000 (-60.53%) | $6,868,000,000 (69.83%) |
Total Investments | $7,592,000,000 (-26.82%) | $10,374,000,000 (-30.91%) | $15,015,000,000 (40.04%) | $10,722,000,000 (307.06%) |
Investments Current | $5,098,000,000 (-10.51%) | $5,697,000,000 (-14.93%) | $6,697,000,000 (72.65%) | $3,879,000,000 (95.51%) |
Investments Non-Current | $2,494,000,000 (-46.68%) | $4,677,000,000 (-43.77%) | $8,318,000,000 (21.55%) | $6,843,000,000 (952.77%) |
Inventory | $117,000,000 (-42.08%) | $202,000,000 (-78.71%) | $949,000,000 (-34.14%) | $1,441,000,000 (2965.96%) |
Trade & Non-Trade Receivables | $358,000,000 (-59.87%) | $892,000,000 (-35.60%) | $1,385,000,000 (-56.38%) | $3,175,000,000 (128.25%) |
Trade & Non-Trade Payables | $405,000,000 (-22.12%) | $520,000,000 (6.78%) | $487,000,000 (61.26%) | $302,000,000 (1577.78%) |
Accumulated Retained Earnings (Deficit) | $10,045,000,000 (-26.17%) | $13,606,000,000 (-25.73%) | $18,320,000,000 (83.97%) | $9,958,000,000 (543.76%) |
Tax Assets | $0 (0%) | $81,000,000 (-91.75%) | $982,000,000 (201.23%) | $326,000,000 (0%) |
Tax Liabilities | $0 (0%) | $63,000,000 (31.25%) | $48,000,000 (-94.52%) | $876,000,000 (0%) |
Total Debt | $710,000,000 (-41.71%) | $1,218,000,000 (21.31%) | $1,004,000,000 (42.41%) | $705,000,000 (240.58%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $710,000,000 (-41.71%) | $1,218,000,000 (21.31%) | $1,004,000,000 (42.41%) | $705,000,000 (240.58%) |
Total Liabilities | $3,241,000,000 (-29.11%) | $4,572,000,000 (-32.12%) | $6,735,000,000 (-36.00%) | $10,524,000,000 (120.35%) |
Liabilities Current | $2,206,000,000 (-26.83%) | $3,015,000,000 (-38.76%) | $4,923,000,000 (-46.07%) | $9,128,000,000 (107.97%) |
Liabilities Non-Current | $1,035,000,000 (-33.53%) | $1,557,000,000 (-14.07%) | $1,812,000,000 (29.80%) | $1,396,000,000 (260.72%) |
MRNA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $3,236,000,000 (-52.75%) | $6,848,000,000 (-64.45%) | $19,263,000,000 (4.29%) | $18,471,000,000 (2200.25%) |
Cost of Revenue | $1,464,000,000 (-68.80%) | $4,693,000,000 (-13.35%) | $5,416,000,000 (106.95%) | $2,617,000,000 (32612.50%) |
Selling General & Administrative Expense | $1,174,000,000 (-24.21%) | $1,549,000,000 (36.84%) | $1,132,000,000 (99.65%) | $567,000,000 (201.60%) |
Research & Development Expense | $4,543,000,000 (-6.23%) | $4,845,000,000 (47.04%) | $3,295,000,000 (65.49%) | $1,991,000,000 (45.33%) |
Operating Expenses | $5,717,000,000 (-10.59%) | $6,394,000,000 (44.43%) | $4,427,000,000 (73.06%) | $2,558,000,000 (64.18%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | -$46,000,000 (-105.96%) | $772,000,000 (-36.36%) | $1,213,000,000 (12.00%) | $1,083,000,000 (36000.00%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$3,561,000,000 (24.46%) | -$4,714,000,000 (-156.37%) | $8,362,000,000 (-31.47%) | $12,202,000,000 (1733.47%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$3,561,000,000 (24.46%) | -$4,714,000,000 (-156.37%) | $8,362,000,000 (-31.47%) | $12,202,000,000 (1733.47%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$3,561,000,000 (24.46%) | -$4,714,000,000 (-156.37%) | $8,362,000,000 (-31.47%) | $12,202,000,000 (1733.47%) |
Weighted Average Shares | $384,000,000 (0.52%) | $382,000,000 (-3.05%) | $394,000,000 (-2.23%) | $403,000,000 (5.77%) |
Weighted Average Shares Diluted | $384,000,000 (0.52%) | $382,000,000 (-8.17%) | $416,000,000 (-3.48%) | $431,000,000 (13.12%) |
Earning Before Interest & Taxes (EBIT) | -$3,607,000,000 (8.50%) | -$3,942,000,000 (-141.17%) | $9,575,000,000 (-27.93%) | $13,285,000,000 (1885.62%) |
Gross Profit | $1,772,000,000 (-17.77%) | $2,155,000,000 (-84.44%) | $13,847,000,000 (-12.66%) | $15,854,000,000 (1894.21%) |
Operating Income | -$3,945,000,000 (6.94%) | -$4,239,000,000 (-145.00%) | $9,420,000,000 (-29.15%) | $13,296,000,000 (1842.60%) |
MRNA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $1,949,000,000 (-53.66%) | $4,206,000,000 (181.26%) | -$5,176,000,000 (39.27%) | -$8,523,000,000 (-409.75%) |
Net Cash Flow from Financing | $56,000,000 (104.07%) | -$1,377,000,000 (60.06%) | -$3,448,000,000 (-294.96%) | -$873,000,000 (-142.94%) |
Net Cash Flow from Operations | -$3,004,000,000 (3.66%) | -$3,118,000,000 (-162.60%) | $4,981,000,000 (-63.43%) | $13,620,000,000 (571.93%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$999,000,000 (-245.67%) | -$289,000,000 (92.07%) | -$3,643,000,000 (-186.25%) | $4,224,000,000 (76.88%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$85,000,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $3,000,000,000 (-39.98%) | $4,998,000,000 (204.65%) | -$4,776,000,000 (42.03%) | -$8,239,000,000 (-413.65%) |
Capital Expenditure | -$1,051,000,000 (-48.66%) | -$707,000,000 (-76.75%) | -$400,000,000 (-40.85%) | -$284,000,000 (-317.65%) |
Issuance (Repayment) of Debt Securities | -$10,000,000 (96.30%) | -$270,000,000 (-46.74%) | -$184,000,000 (-31.43%) | -$140,000,000 (-2233.33%) |
Issuance (Purchase) of Equity Shares | $66,000,000 (105.96%) | -$1,107,000,000 (66.08%) | -$3,264,000,000 (-345.29%) | -$733,000,000 (-135.95%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $429,000,000 (40.66%) | $305,000,000 (34.96%) | $226,000,000 (59.15%) | $142,000,000 (52.69%) |
Depreciation Amortization & Accretion | $189,000,000 (-69.57%) | $621,000,000 (78.45%) | $348,000,000 (50.00%) | $232,000,000 (149.46%) |
MRNA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 54.80% (73.97%) | 31.50% (-56.19%) | 71.90% (-16.20%) | 85.80% (-13.33%) |
Profit Margin | -110.00% (-59.88%) | -68.80% (-258.53%) | 43.40% (-34.34%) | 66.10% (171.08%) |
EBITDA Margin | -105.60% (-117.73%) | -48.50% (-194.17%) | 51.50% (-29.64%) | 73.20% (190.26%) |
Return on Average Equity (ROAE) | -30.10% (-0.67%) | -29.90% (-164.58%) | 46.30% (-66.98%) | 140.20% (564.24%) |
Return on Average Assets (ROAA) | -22.80% (-1.33%) | -22.50% (-170.98%) | 31.70% (-51.68%) | 65.60% (485.88%) |
Return on Sales (ROS) | -111.50% (-93.58%) | -57.60% (-215.90%) | 49.70% (-30.88%) | 71.90% (177.56%) |
Return on Invested Capital (ROIC) | -29.10% (-12.79%) | -25.80% (-145.18%) | 57.10% (-82.44%) | 325.10% (736.20%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -4.48 (44.45%) | -8.07 (-195.47%) | 8.45 (0.84%) | 8.38 (115.72%) |
Price to Sales Ratio (P/S) | 4.93 (-11.07%) | 5.55 (51.01%) | 3.67 (-33.69%) | 5.54 (-88.82%) |
Price to Book Ratio (P/B) | 1.47 (-46.36%) | 2.74 (-24.16%) | 3.61 (-50.43%) | 7.28 (-54.90%) |
Debt to Equity Ratio (D/E) | 0.3 (-10.00%) | 0.33 (-6.25%) | 0.35 (-52.69%) | 0.74 (-60.11%) |
Earnings Per Share (EPS) | -9.28 (24.74%) | -12.33 (-158.00%) | 21.26 (-29.86%) | 30.31 (1646.43%) |
Sales Per Share (SPS) | 8.43 (-52.99%) | 17.93 (-63.33%) | 48.89 (6.67%) | 45.83 (2074.29%) |
Free Cash Flow Per Share (FCFPS) | -10.56 (-5.46%) | -10.01 (-186.12%) | 11.63 (-64.86%) | 33.09 (543.56%) |
Book Value Per Share (BVPS) | 28.39 (-21.72%) | 36.27 (-25.28%) | 48.54 (38.28%) | 35.1 (422.15%) |
Tangible Assets Book Value Per Share (TABVPS) | 36.83 (-23.65%) | 48.24 (-26.50%) | 65.63 (7.21%) | 61.21 (217.87%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (55.56%) | -9 (-228.57%) | 7 (0.00%) | 7 (112.96%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.58 (58.03%) | -10.92 (-261.75%) | 6.75 (-6.68%) | 7.23 (111.76%) |
Asset Turnover | 0.21 (-36.39%) | 0.33 (-55.21%) | 0.73 (-26.49%) | 0.99 (442.62%) |
Current Ratio | 3.67 (7.18%) | 3.42 (25.55%) | 2.73 (54.91%) | 1.76 (22.72%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$4,055,000,000 (-6.01%) | -$3,825,000,000 (-183.50%) | $4,581,000,000 (-65.65%) | $13,336,000,000 (580.76%) |
Enterprise Value (EV) | $15,660,724,581 (-56.81%) | $36,258,693,402 (-45.87%) | $66,980,495,842 (-31.49%) | $97,769,070,867 (144.17%) |
Earnings Before Tax (EBT) | -$3,607,000,000 (8.50%) | -$3,942,000,000 (-141.17%) | $9,575,000,000 (-27.93%) | $13,285,000,000 (1885.62%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$3,418,000,000 (-2.92%) | -$3,321,000,000 (-133.47%) | $9,923,000,000 (-26.59%) | $13,517,000,000 (2176.34%) |
Invested Capital | $10,719,000,000 (-21.88%) | $13,722,000,000 (-26.75%) | $18,734,000,000 (99.34%) | $9,398,000,000 (1669.87%) |
Working Capital | $5,893,000,000 (-19.38%) | $7,310,000,000 (-14.08%) | $8,508,000,000 (22.54%) | $6,943,000,000 (263.70%) |
Tangible Asset Value | $14,142,000,000 (-23.25%) | $18,426,000,000 (-28.74%) | $25,858,000,000 (4.82%) | $24,669,000,000 (236.23%) |
Market Capitalization | $16,000,724,581 (-57.80%) | $37,918,693,402 (-45.05%) | $69,006,495,842 (-32.99%) | $102,976,070,867 (149.10%) |
Average Equity | $11,839,250,000 (-24.97%) | $15,780,250,000 (-12.54%) | $18,043,750,000 (107.33%) | $8,702,750,000 (251.32%) |
Average Assets | $15,588,500,000 (-25.67%) | $20,971,250,000 (-20.54%) | $26,391,500,000 (41.82%) | $18,609,750,000 (324.36%) |
Invested Capital Average | $12,393,500,000 (-18.93%) | $15,286,500,000 (-8.88%) | $16,776,750,000 (310.57%) | $4,086,250,000 (180.51%) |
Shares | 384,817,811 (0.93%) | 381,283,996 (-0.75%) | 384,180,469 (-5.25%) | 405,449,527 (2.46%) |
